🎙️ VP of Global Sales Doug Heath and VP of Marketing Anna Turkington discuss Intelligent Bio Solutions’ growth outlook, global expansion, and strategy. Tune in: hubs.li/Q03v6s8v0 🇺🇸 #NASDAQ: $INBS

We aim to preserve employee dignity through quick, non-invasive, and hygienic analysis of fingertip sweat. Read more: hubs.li/Q03qkfLb0 🇺🇸 $INBS #NASDAQ #MedicalTechnologyStocks2025

📩 Get news, reports, event updates, and presentations from Intelligent Bio Solutions delivered straight to your inbox. Subscribe: hubs.li/Q03qkfxl0 🇺🇸 $INBS #Newsletter #NASDAQ #MedicalTechnologyStocks2025 #Stocks

🗞️ The UNODC's 2024 World Drug Day Report revealed a global cocaine surge and escalating trafficking risks in Southeast Asia. Read the article: hubs.li/Q03vy4YN0 🇺🇸 $INBS #DrugScreening #PortableTesting #MedicalTechnologyStocks2025 #NASDAQ

How accurate is our Intelligent Fingerprinting Drug Screening System compared to traditional methods? Hear from our CEO Harry Simeonidis. 🎬 Full interview: hubs.li/Q03tZfgL0 🇺🇸 $INBS #DrugScreening #PortableTesting #MedicalTechnologyStocks2025 #NASDAQ

Our Intelligent Fingerprinting Drug Screening System combines: -Administrator-supervised testing to prevent tampering -Self-locking sample seals that secure integrity No compromises. Just reliable, tamper-proof results. Read: hubs.li/Q03tZfY_0 🇺🇸 $INBS #NASDAQ

With over 450 active customers, our Intelligent Fingerprinting Drug Screening System is trusted across industries like construction and manufacturing. CEO Harry Simeonidis shares more on our customer segments and market focus. 🎬: hubs.li/Q03wq6Cp0 🇺🇸 $INBS #NASDAQ

$INBS to present PK study data at #ADLM2025. Results show fingerprint sweat mirrors codeine levels in blood and saliva. Study demonstrates fingerprint sweat provides a reliable sample matrix for drug detection. Read more: hubs.li/Q03wzXMJ0 #drugtesting #drugscreening

Screen anytime, anywhere with our portable Intelligent Fingerprinting Drug Screening System. Workplace testing has never been more flexible. For more details: hubs.li/Q03vy4Y_0 🇺🇸 $INBS #MedicalTechnologyStocks2025 #NASDAQ

Our VP of Product Development Peter Passaris and VP of Global Quality and Operations Callistus Sequeira discuss our new language integrations for the drug screening reader and key company updates. Watch: hubs.li/Q03w_tbh0 🇺🇸 $INBS #NASDAQ

$INBS expands non-invasive testing portfolio with the SmarTest Sweat Patch. The Patch enables continuous #noninvasive drug detection for 7-10 days, complementing INBS's existing drug screening system & supporting short & long-term detection needs. hubs.ly/Q03w_Vc20 #NASDAQ

$INBS is now a global distributor of the SmarTest® Patch, bringing continuous, non-invasive drug detection to markets outside the U.S. & Canada & strengthening its position as a global leader in non-invasive testing. hubs.li/Q03xpm6x0 DrugTesting #MedTech #GlobalExpansion

In 2021, drug overdose deaths surged across all age groups—driven mainly by the synthetic opioid fentanyl and its analogs. 💡 Read this expert discussion on the rise in opioid overdose deaths: hubs.li/Q03vyrhM0 🇺🇸 $INBS #Health #MedicalTechnologyStocks2025 #NASDAQ

💬 CEO Harry Simeonidis and CFO Spiro Sakiris discuss our key investment highlights and growth opportunities. 🎬 Watch the full interview: hubs.li/Q03tZgcw0 🇺🇸 $INBS #Health #MedicalTechnologyStocks2025 #NASDAQ

🌎 By adapting to local markets and entering new industries, we're bringing rapid, evidence-based drug testing where it's needed most to improve safety and well-being. Learn more about our mission: hubs.li/Q03yp9fs0 🇺🇸 $INBS #NASDAQ #Stocks

🔬 Our Intelligent Fingerprinting System collects samples instantly and uses batch testing to deliver drug screening results in minutes. Check out the technology behind the drug testing: hubs.li/Q03tZkh90 🇺🇸 $INBS #MedicalTechnologyStocks2025 #NASDAQ

Our work is grounded in science and driven by a team committed to doing things differently. 👨🏻‍🔬👩‍🔬 Meet our team: hubs.li/Q03vyrWz0 🇺🇸 $INBS #Health #MedicalTechnologyStocks2025 #NASDAQ

$INBS secures major drug testing contract with one of London’s largest public transport operators, covering 14 sites and 4,400+ staff. The adoption of INBS’s tech highlights growing demand for scalable, dignified testing across safety-critical sectors. hubs.li/Q03zsGrY0